Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Champions Oncology, Inc.

TRADE

NASDAQ: CSBRHealthcare / Biotechnology / USA
12.30+0.73+6.31%Vol 690 1961Y Perf 240.74%
Sep 18th, 2018 16:00
BID11.88 ASK12.68
Open11.50 Previous Close11.57
Pre-Market11.50 After-Trading-
 -0.07 -0.61%  - -%
Target Price
12.33 
Analyst Rating
Strong Buy 1.00
Potencial %
0.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    20.59
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
     38.26
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)136 
Earnings Rating
Price Range Ratio 52wk %
92.96 
Earnings Date

Today's Price Range

11.5013.00

 

52wk Range

3.0513.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
45.53%
3 Months
83.65%
6 Months
214.40%
1 Year
240.74%
3 Years
58.49%
5 Years
-43.28%

Quotes

Name / TickerPriceChg.Chg.%
CSBR12.300.73006.31
AAPL218.240.36000.17
GOOG1 161.225.17000.45
MSFT113.211.07000.95
XOM83.630.22000.26
WFC54.500.19000.35
JNJ140.540.58000.41
FB160.30-0.2800-0.17
GE12.66-0.0400-0.31
JPM114.300.46000.40
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.70
Current Ratio 0.70
Long Term Debt to Total Capital 0.20
Total Debt to Equity 0.47
Interest Coverage -
Leverage Ratio 20.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin193.60
EBIT Margin-7.10
EBITDA Margin1.10
Pre-tax Profit Margin-71.00
Profit Margin-1.51
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 38 939.20
PS Ratios 5.45
Price to Cash Flow 23.60
Price to Free Cash Flow 221.20
Cash Flow Per Share -0.11
Price to Tangible Book-1 743.55
Book Value per Share0.00
Enterprise Value (in ths.)115 962
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-513.10
ROE last 12 Months -71.55
Return on Assets (5Y Avg) -106.67
ROA last 12 Months -4.30
Return on Capital (5Y Avg) -686.98
ROC last 12 Months -230.41
Return on invested Capital Q 82.04
Return on invested Capital Y-732.51
Assets Turnover2.50
Receivables Turnover6.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)21 432
Revenue per Share 1.94
Revenue Growth 3 Years 26.78
Revenue Growth 5 Years 16.15
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 20190.000.04-
Q04 2018-0.04-0.06-50.00
Q04 2016--0.30-
Q03 2016--0.28-
Q02 2016--0.29-
Q01 2016--0.33-
Q04 2015--0.05-
Q03 2015--0.04-
Earnings Per EndEstimateRevision %Trend
4/2018 QR-0.04--
4/2018 FY-0.12--
7/2018 QR0.01--
4/2019 FY0.04--
Next Report Date13th Sep 2018
Estimated EPS Next Report0.01
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume690 196
Shares Outstanding (in ths.)11 040
Trades Count2 363
Dollar Volume8 160 745
Avg. Volume67 362
Avg. Weekly Volume706 340
Avg. Monthly Volume206 255
Avg. Quarterly Volume132 295

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

35%65%

Bearish Bullish

47%53%

Bearish Bullish

47%53%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x